ME01270B - Cjepiva protiv zaraznog bronhitisa dobivena iz sojeva virusa sličnog ib-qx - Google Patents

Cjepiva protiv zaraznog bronhitisa dobivena iz sojeva virusa sličnog ib-qx

Info

Publication number
ME01270B
ME01270B MEP-2011-23A MEP2311A ME01270B ME 01270 B ME01270 B ME 01270B ME P2311 A MEP2311 A ME P2311A ME 01270 B ME01270 B ME 01270B
Authority
ME
Montenegro
Prior art keywords
viruses
infectious bronchitis
similar
present
strains
Prior art date
Application number
MEP-2011-23A
Other languages
English (en)
Inventor
Harmen Jacob Geerligs
Cindy Aleida Maria Meinders
Geert Jan Boelm
Bastiana Geertruida Elisabeth Stuurman
Original Assignee
Zoetis Services Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zoetis Services Llc filed Critical Zoetis Services Llc
Publication of ME01270B publication Critical patent/ME01270B/me

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units
    • C12N7/08—Inactivation or attenuation by serial passage of virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/544—Mucosal route to the airways
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20061—Methods of inactivation or attenuation
    • C12N2770/20064—Methods of inactivation or attenuation by serial passage

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Pulmonology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Ovaj izum odnosi se na viruse koji uzrokuju zarazni bronhitis (IB), dobivene iz nedavno identificiranog genotipa virusa IB, poznatog kao IB-QX, ili na viruse genetski srodne IB-QX, koje se u ovoj specifikaciji navodi kao viruse sl i č ne IB-QX. Virusi IB prema ovom izumu mogu biti   ž ivi i atenuirani ili inaktivirani.   Ž ive, atenuirane viruse IB prema ovom izumu m o ž e se dobiti serijskim pas a ž ama virusa sl i č nih IB-QX.  Viruse IB prema ovom izumu m o ž e se, izm e đ u ostalog,  upotrijeb iti za cijepiva protiv  virusa  IB-QX i virusa sl i č nih IB-QX. Do sada su se poznati cjepivni sojevi virusa IB pokazali kao  ne djelotvorni u z a š titi protiv zaraznog bronhitisa kojeg uzrokuju  virus  IB-QX i virusi sl i č ni IB-QX.  
MEP-2011-23A 2008-08-08 2009-08-07 Cjepiva protiv zaraznog bronhitisa dobivena iz sojeva virusa sličnog ib-qx ME01270B (me)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8722808P 2008-08-08 2008-08-08
PCT/US2009/053085 WO2010017440A1 (en) 2008-08-08 2009-08-07 Infectious bronchitis vaccines derived from ib-qx-like strains

Publications (1)

Publication Number Publication Date
ME01270B true ME01270B (me) 2013-06-20

Family

ID=41211689

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-2011-23A ME01270B (me) 2008-08-08 2009-08-07 Cjepiva protiv zaraznog bronhitisa dobivena iz sojeva virusa sličnog ib-qx

Country Status (27)

Country Link
US (1) US9296991B2 (me)
EP (1) EP2331682B1 (me)
JP (3) JP2011530294A (me)
KR (2) KR20110038181A (me)
CN (1) CN102239252B (me)
AR (1) AR072976A1 (me)
AU (1) AU2009279528A1 (me)
BR (1) BRPI0917447A2 (me)
CA (1) CA2732822C (me)
CL (1) CL2011000262A1 (me)
CO (1) CO6351810A2 (me)
CY (1) CY1121567T1 (me)
DK (1) DK2331682T3 (me)
ES (1) ES2702089T3 (me)
HK (1) HK1159164A1 (me)
HU (1) HUE041481T2 (me)
LT (1) LT2331682T (me)
ME (1) ME01270B (me)
MX (1) MX339731B (me)
PL (1) PL2331682T3 (me)
PT (1) PT2331682T (me)
RU (1) RU2568053C2 (me)
SI (1) SI2331682T1 (me)
TR (1) TR201819340T4 (me)
UA (1) UA103330C2 (me)
WO (1) WO2010017440A1 (me)
ZA (1) ZA201100849B (me)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10125401B2 (en) * 2012-12-18 2018-11-13 Asia-Pacific Special Nutrients Sdn. Bhd. High resolution melt genotyping of IBV, CSFV and NDV
CN103028112B (zh) * 2012-12-31 2014-08-06 青岛易邦生物工程有限公司 一种鸡新城疫和传染性支气管炎二联活疫苗
CN103146654B (zh) * 2013-03-25 2014-07-30 浙江诺倍威生物技术有限公司 一株人工弱化的鸡传染性支气管炎病毒及其应用
AU2017274332B2 (en) 2016-06-02 2024-06-27 Zoetis Services Llc Vaccine against infectious bronchitis
CN108950068B (zh) * 2018-07-18 2021-05-07 浙江大学 一种鸡传染性支气管炎病毒qx型毒株鉴别检测试剂盒
CN112996537A (zh) * 2018-10-31 2021-06-18 勃林格殷格翰动物保健有限公司 具有异源刺突蛋白的4/91 ibv疫苗
WO2024019579A1 (ko) * 2022-07-22 2024-01-25 주식회사 카브 닭전염성기관지염바이러스 약독화주 및 이를 포함하는 백신조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4867975A (en) * 1988-01-27 1989-09-19 University Of Delaware Live attenuated temperature-sensitive avian infectious bronchitis virus vaccines and preparation and use thereof
US5037650A (en) * 1988-03-08 1991-08-06 Akzo N.V. Live combination vaccine
EP0639640B1 (en) 1993-07-30 2000-10-04 Akzo Nobel N.V. Poultry vaccine containing infections bronchitis virus strain 4/91
JPH07206705A (ja) * 1993-11-03 1995-08-08 American Cyanamid Co 生インオボ（ｉｎ ｏｖｏ）ワクチン
US20010046500A1 (en) 2000-02-29 2001-11-29 Berend Jongsma In ovo protection against infectious bronchitis
PL1610817T3 (pl) * 2003-03-03 2010-05-31 Intervet Int Bv Wirus zakaźnego zapalenia oskrzeli ze zmienionym genem wypustek
US7291342B2 (en) * 2003-05-19 2007-11-06 Intervet International B.V. Infectious bronchitis virus vaccine

Also Published As

Publication number Publication date
CN102239252A (zh) 2011-11-09
BRPI0917447A2 (pt) 2015-12-01
JP6397539B2 (ja) 2018-09-26
LT2331682T (lt) 2018-12-10
ZA201100849B (en) 2015-10-28
JP2015144605A (ja) 2015-08-13
RU2011104201A (ru) 2012-08-20
CA2732822A1 (en) 2010-02-11
UA103330C2 (ru) 2013-10-10
JP2017212976A (ja) 2017-12-07
KR101732240B1 (ko) 2017-05-02
PT2331682T (pt) 2018-12-19
CN102239252B (zh) 2015-04-15
AU2009279528A1 (en) 2010-02-11
HK1159164A1 (zh) 2012-07-27
KR20150020623A (ko) 2015-02-26
EP2331682A1 (en) 2011-06-15
PL2331682T3 (pl) 2019-03-29
US9296991B2 (en) 2016-03-29
CY1121567T1 (el) 2020-05-29
TR201819340T4 (tr) 2019-01-21
WO2010017440A1 (en) 2010-02-11
HUE041481T2 (hu) 2019-05-28
SI2331682T1 (sl) 2019-01-31
CL2011000262A1 (es) 2011-05-06
EP2331682B1 (en) 2018-10-24
CA2732822C (en) 2016-09-20
US20110305726A1 (en) 2011-12-15
AR072976A1 (es) 2010-10-06
KR20110038181A (ko) 2011-04-13
ES2702089T3 (es) 2019-02-27
MX339731B (es) 2016-06-08
JP2011530294A (ja) 2011-12-22
DK2331682T3 (en) 2018-12-10
MX2011001514A (es) 2011-03-29
CO6351810A2 (es) 2011-12-20
RU2568053C2 (ru) 2015-11-10

Similar Documents

Publication Publication Date Title
ME01270B (me) Cjepiva protiv zaraznog bronhitisa dobivena iz sojeva virusa sličnog ib-qx
CO6390076A2 (es) Inhibidores de hcv ns5a
CO6390077A2 (es) Inhibidores de hacv ns5a
CY1118567T1 (el) Αναστολεις του ιου της ηπατιτιδας c
BRPI0913012A2 (pt) vírus do nilo ocidental/da dengue quiméricos
ME01140B (me) Virus goveđe virusne dijareje s modifikovanim erns proteinom
TW201613558A (en) Novel vaccine compositions for porcine epidemic diarrhea virus and porcine deltacoronavirus
NO20090897L (no) Vaksine
EA201591888A1 (ru) Репликационно-дефектные вакцины и вакцинные векторы против флавивирусов
CL2012000447A1 (es) Composición o vacuna que comprende un vector viral de un paramixovirus aviar 8 (apmv-8) recombinante; método para producir dicho vector; y uso para preparar medicamento útil para inducir una respuesta inmunológica.
CO7461133A2 (es) Parvovirus 5a porcino, métodos de uso y vacuna
CO6430434A2 (es) Nuevas composiciones de vacunas con pertussis acelular y método de fabricación de las mismas
CO7461135A2 (es) Parvovirus porcino 5b, métodos de uso y vacuna
WO2008115314A3 (en) Flavivirus vaccine vector against influenza virus
PH12018501750A1 (en) Porcine reproductive and respiratory syndrome vaccine virus
CU20120057A7 (es) Composición vacunal contra el virus del dengue, kit y plásmido
CO6670515A2 (es) Vectores de parapoxvirus
UY35418A (es) Vacuna que proporciona protección frente a diferentes Picornavirus humanos.
BRPI0916186B8 (pt) vetor de plasmídeo e seu uso, vacina para febre amarela e para vírus de rna infeccioso e vírus atenuado vivo clonalmente purificado homogêneo e seu uso
PE20090214A1 (es) Perfil de temperatura de dos etapas para la propagacion de los virus
BRPI0819031A2 (pt) processo para preparar cepas virais atenuadas, vírus atenuado, uso de uma cepa viral atenuada e vacina baseada em vírus atenuado vivos.
CL2019003232A1 (es) Composiciones de vacunas para virus de necrosis pancreática infecciosas (ipnv).
WO2012143141A3 (fr) Compositions antivirales dirigees contre la nucleoproteine des virus influenza
CU23561A1 (es) Un flavivirus como un vector para antígenos heterólogos
UA108904C2 (xx) Противірусні сполуки